Elena Barisone

2.6k total citations
35 papers, 687 citations indexed

About

Elena Barisone is a scholar working on Public Health, Environmental and Occupational Health, Pediatrics, Perinatology and Child Health and Hematology. According to data from OpenAlex, Elena Barisone has authored 35 papers receiving a total of 687 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Public Health, Environmental and Occupational Health, 19 papers in Pediatrics, Perinatology and Child Health and 13 papers in Hematology. Recurrent topics in Elena Barisone's work include Acute Lymphoblastic Leukemia research (27 papers), Childhood Cancer Survivors' Quality of Life (19 papers) and Acute Myeloid Leukemia Research (9 papers). Elena Barisone is often cited by papers focused on Acute Lymphoblastic Leukemia research (27 papers), Childhood Cancer Survivors' Quality of Life (19 papers) and Acute Myeloid Leukemia Research (9 papers). Elena Barisone collaborates with scholars based in Italy, United States and Germany. Elena Barisone's co-authors include Giuseppe Basso, Maurizio Aricò, Carmelo Rizzari, Chiara Messina, Andrea Pession, Giuseppe Masera, Maria Grazia Valsecchi, Daniela Silvestri, Nicola Santoro and Nicoletta Bertorello and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Elena Barisone

35 papers receiving 667 citations

Peers

Elena Barisone
Audrey Contet France
M.L. te Winkel Netherlands
Hester A. de Groot‐Kruseman Netherlands
Riitta Niinimäki Finland
Kathrine Grell Denmark
Goda Vaitkevičienė Lithuania
Ólafur Gísli Jónsson Iceland
Marit Hellebostad Norway
Anna Berg Netherlands
Amparo Verdeguer Spain
Audrey Contet France
Elena Barisone
Citations per year, relative to Elena Barisone Elena Barisone (= 1×) peers Audrey Contet

Countries citing papers authored by Elena Barisone

Since Specialization
Citations

This map shows the geographic impact of Elena Barisone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elena Barisone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elena Barisone more than expected).

Fields of papers citing papers by Elena Barisone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elena Barisone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elena Barisone. The network helps show where Elena Barisone may publish in the future.

Co-authorship network of co-authors of Elena Barisone

This figure shows the co-authorship network connecting the top 25 collaborators of Elena Barisone. A scholar is included among the top collaborators of Elena Barisone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elena Barisone. Elena Barisone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blom, Johanna Maria Catharina, Elena Barisone, Monica Cellini, et al.. (2022). The Use of Psychotropic Medication in Pediatric Oncology for Acute Psychological and Psychiatric Problems: Balancing Risks and Benefits. Children. 9(12). 1878–1878. 4 indexed citations
2.
3.
Franca, Raffaella, Gabriele Stocco, Franco Locatelli, et al.. (2019). PACSIN2 rs2413739 influence on thiopurine pharmacokinetics: validation studies in pediatric patients. The Pharmacogenomics Journal. 20(3). 415–425. 16 indexed citations
4.
Ferrari, Andrea, Roberto Rondelli, Andrea Pession, et al.. (2016). Adolescents with Cancer in Italy: Improving Access to National Cooperative Pediatric Oncology Group (AIEOP) Centers. Pediatric Blood & Cancer. 63(6). 1116–1119. 7 indexed citations
5.
Buldini, Barbara, Daniela Silvestri, Franco Locatelli, et al.. (2014). FLT3-ITD As a Target for Minimal Residual Disease Monitoring in Early T-Cell Precursor (ETP) Acute Lymphoblastic Leukemia. Blood. 124(21). 1073–1073. 1 indexed citations
6.
Parasole, Rosanna, Fara Petruzziello, Chiara Messina, et al.. (2014). Toxicity and efficacy of intrathecal liposomal cytarabine in children with leukemia/lymphoma relapsing in the central nervous system: a retrospective multicenter study. Leukemia & lymphoma. 56(3). 650–655. 6 indexed citations
7.
Santoro, Nicola, Antonella Colombini, Daniela Silvestri, et al.. (2013). Screening for Coagulopathy and Identification of Children With Acute Lymphoblastic Leukemia at a Higher Risk of Symptomatic Venous Thrombosis. Journal of Pediatric Hematology/Oncology. 35(5). 348–355. 33 indexed citations
8.
Miano, Maurizio, Angela Pistorio, Maria Caterina Putti, et al.. (2012). Clofarabine, cyclophosphamide and etoposide for the treatment of relapsed or resistant acute leukemia in pediatric patients. Leukemia & lymphoma. 53(9). 1693–1698. 29 indexed citations
9.
Quarello, Paola, Massimo Berger, Riccardo Masetti, et al.. (2012). FLAG-liposomal Doxorubicin (Myocet) Regimen for Refractory or Relapsed Acute Leukemia Pediatric Patients. Journal of Pediatric Hematology/Oncology. 34(3). 208–216. 14 indexed citations
10.
Pillon, Marta, Maurizio Aricò, Giuseppe Basso, et al.. (2010). Long‐term results of AIEOP‐8805 protocol for acute B‐cell lymphoblastic leukemia of childhood. Pediatric Blood & Cancer. 56(4). 544–550. 1 indexed citations
11.
Hempel, Georg, Mary V. Relling, Giulio Rossi, et al.. (2009). Pharmacokinetics of daunorubicin and daunorubicinol in infants with leukemia treated in the interfant 99 protocol. Pediatric Blood & Cancer. 54(3). 355–360. 19 indexed citations
12.
Conter, Valentino, Maria Grazia Valsecchi, Maurizio Aricò, et al.. (2009). Results of the AIEOP-BFM ALL 2000 Study for Childhood Acute Lymphoblastic Leukemia IN AIEOP High Risk Patients.. Blood. 114(22). 319–319. 1 indexed citations
13.
Einaudi, Silvia, Nicoletta Bertorello, Nicoletta Masera, et al.. (2007). Adrenal axis function after high‐dose steroid therapy for childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 50(3). 537–541. 68 indexed citations
14.
Aricò, Maurizio, Maria Grazia Valsecchi, Carmelo Rizzari, et al.. (2007). Long Term Results of the AIEOP-All-95 Trial for Childhood Acute Lymphoblastic Leukemia. An Insight on the Prognostic Value of Dna Index in the Frame of BFM-Based Chemotherapy.. Blood. 110(11). 1440–1440. 1 indexed citations
15.
Saracco, Paola, Nicoletta Bertorello, Silvia Einaudi, et al.. (2005). Steroid Withdrawal Syndrome During Steroid Tapering in Childhood Acute Lymphoblastic Leukemia. Journal of Pediatric Hematology/Oncology. 27(3). 141–144. 18 indexed citations
16.
Garte, Seymour, Emanuela Taioli, Francesca Crosti, et al.. (2000). Deletion of parental GST genes as a possible susceptibility factor in the etiology of infant leukemia. Leukemia Research. 24(11). 971–974. 13 indexed citations
17.
Volpe, Gisella, Giuseppe Basso, Enrico Gottardi, et al.. (1997). Outcome and lineage involvement in t(12;21) childhood acute lymphoblastic leukaemia. British Journal of Haematology. 97(2). 460–462. 25 indexed citations
18.
19.
Aricò, Maurizio, Giuseppe Basso, Luigi Zanesco, et al.. (1995). Good steroid response in vivo predicts a favorable outcome in children with T-cell acute lymphoblastic leukemia. Cancer. 75(7). 1684–1693. 60 indexed citations
20.
Silengo, Margherita, et al.. (1992). Monosomy 20 in childhood acute lymphoblastic leukemia. Cancer Genetics and Cytogenetics. 59(2). 177–179. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Audrey Contet Breakdown of academic impact, for papers by M.L. te Winkel Breakdown of academic impact, for papers by Hester A. de Groot‐Kruseman Breakdown of academic impact, for papers by Riitta Niinimäki Breakdown of academic impact, for papers by Kathrine Grell Breakdown of academic impact, for papers by Goda Vaitkevičienė Breakdown of academic impact, for papers by Ólafur Gísli Jónsson Breakdown of academic impact, for papers by Marit Hellebostad Breakdown of academic impact, for papers by Anna Berg Breakdown of academic impact, for papers by Amparo Verdeguer
Rankless by CCL
2026